Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Pretreatment plasma sCD14 as a prognostic indicator in advanced non-small cell lung cancer patients undergoing immunotherapy

Fig. 4

CD14 gene and protein expression in the pan-cancer cohort. (A) Comparison of CD14 mRNA expression between normal and tumor samples across the pan-cancer cohort. (B) Comparison of CD14 expression in LUAD and LUSC subtypes. (C) Comparison of CD14 protein expression between normal and tumor samples in the pan-cancer cohort. (D) Comparison of CD14 protein expression in LUAD, LUSC, and normal samples. (Abbreviation: mRNA: messenger RNA; LUAD: lung adenocarcinoma; LUSC: lung squamous cell carcinoma. Mann-Whitney test was performed between groups)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us